Authors:
SKINNER R
PEARSON ADJ
ENGLISH MW
PRICE L
WYLLIE RA
COULTHARD MG
CRAFT AW
Citation: R. Skinner et al., CISPLATIN DOSE-RATE AS A RISK FACTOR FOR NEPHROTOXICITY IN CHILDREN, British Journal of Cancer, 77(10), 1998, pp. 1677-1682
Authors:
ASHRAF MS
SKINNER R
ENGLISH MW
CRAFT AW
PEARSON ADJ
Citation: Ms. Ashraf et al., LATE REVERSIBILITY OF CHRONIC IFOSFAMIDE-ASSOCIATED NEPHROTOXICITY INA CHILD, Medical and pediatric oncology, 28(1), 1997, pp. 62-64
Authors:
PENG B
TILBY MJ
ENGLISH MW
PRICE L
PEARSON ADJ
BODDY AV
NEWELL DR
Citation: B. Peng et al., PLATINUM-DNA ADDUCT FORMATION IN LEUKOCYTES OF CHILDREN IN RELATION TO PHARMACOKINETICS AFTER CISPLATIN AND CARBOPLATIN THERAPY, British Journal of Cancer, 76(11), 1997, pp. 1466-1473
Authors:
ENGLISH MW
SKINNER R
PEARSON ADJ
PRICE L
WYLLIE R
CRAFT AW
Citation: Mw. English et al., THE INFLUENCE OF IFOSFAMIDE SCHEDULING ON ACUTE NEPHROTOXICITY IN CHILDREN, British Journal of Cancer, 75(9), 1997, pp. 1356-1359
Authors:
ENGLISH MW
LOWIS SP
PENG B
BODDY A
NEWELL DR
PRICE L
PEARSON ADJ
Citation: Mw. English et al., PHARMACOKINETICALLY GUIDED DOSING OF CARBOPLATIN AND ETOPOSIDE DURINGPERITONEAL-DIALYSIS AND HEMODIALYSIS, British Journal of Cancer, 73(6), 1996, pp. 776-780
Authors:
BIN P
BODDY AV
ENGLISH MW
PEARSON ADJ
PRICE L
TILBY MJ
NEWELL DR
Citation: P. Bin et al., THE COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF CISPLATIN AND CARBOPLATIN IN PEDIATRIC-PATIENTS - A REVIEW, Anticancer research, 14(6A), 1994, pp. 2279-2283